Source: https://www.prarulebook.co.uk/pra-rules/credit-valuation-adjustment-risk/01-01-2027?p=1 · captured 2026-09-28 · checked 2026-09-28 · 7d85aec8

2301
2302\[{\hat{\omega}}_{T}= {\rm max} \left({\bar{\omega}}_t, \frac{K_1^{b3.1\ scope}}{K_T^{b3.1\ scope}}\cdot {\bar{\omega}}_t + \frac{K_T^{b3.1\ scope}-K_1^{b3.1\ scope}}{K_T^{b3.1\ scope}}\cdot 100\% \right)\]
2303
2304where:
2305
2306\[T=\]
2307
2308the date of calculation of own funds requirements for CVA risk;
2309
2310\[\bar{\omega}_t=\]
2311
2312the immediate discount scalar, calculated in accordance with 7.2;
2313
2314\[K_1^{b3.1 scope}=\]
2315
2316calculated in accordance with 7.2;
2317
2318\[K_T^{b3.1 scope}=\]
2319
2320the amount of own funds requirements for CVA risk on all covered transactions at T, calculated using the reduced version of BA-CVA at 4.2 and the exposure value calculated in accordance with Counterparty Credit Risk (CRR) Part Article 274.
2321
232201/01/2027
2323
23247.2
2325
2326For the purposes of 7.1(2), the intermediate discount scalar (\[\bar{\omega}_{t}\]) must be calculated in accordance with the following formula:
2327
2328\[{\bar{\omega}}_{t}={\rm max} \left( \omega_t, 100\% - \frac{K_1^{b3.1\ scope}-\ K_1^{CRR\ scope}}{K_1^{b3.1\ scope}}\cdot \frac{\left( 5-t \right)}{5}\cdot \frac{1-\omega_t}{1-\omega}\right)\]
2329
2330where:
2331
2332t =
2333
2334elapsed time of the transitional period, where t=2 on 1 January 2027, t=3 on 1 January 2028, and t=4 on 1 January 2029;
2335
2336ωt =
2337
2338the transitional weighting cap which must be applied as prescribed in the table below:
2339
2340Date
2341
2342Transitional weighting cap ωt
2343
2344From and including 1 January 2027 to and including 31 December 2027
2345
234670%
2347
2348From and including 1 January 2028 to an including 31 December 2028
2349
235080%
2351
2352From and including 1 January 2029 to and including 31 December 2029
2353
235490%
2355
2356\[\rm K_1^{\rm b3.1\ scope}\] =
2357
2358the own funds requirements for CVA risk on all covered transactions at t=1, calculated using the reduced version of BA-CVA at 4.2 and the exposure value calculated in accordance with Counterparty Credit Risk (CRR) Part Article 274;
2359
2360\[\rm K_1^{\rm CRR\ scope}\] =
2361
2362the amount of own funds requirements for CVA risk on all covered transactions at t=1, excluding transactions with counterparties referred to in 7.1(1), calculated using the reduced version of BA-CVA at 4.2 and the exposure value calculated in accordance with Counterparty Credit Risk (CRR) Part Article 274;
2363
2364\[\frac{K_1^{b3.1\ scope}-\ K_1^{CRR\ scope}}{K_1^{b3.1\ scope}}\] =
2365
2366the proportion of transactions with counterparties referred to in 7.1(1) that were excluded from CVA risk capital requirements prior to 1 January 2027, relative to total own funds requirements for CVA risk calculated at t=1 using the reduced version of BA-CVA at 4.2 and the exposure value calculated in accordance with Counterparty Credit Risk (CRR) Part Article 274 (the ‘legacy exempt ratio’);
2367
2368\[\frac{\left( 5-t \right)}{5}\] =
2369
2370time discount factor, that linearly reduces the proportion of legacy exempt trades to reflect the assumed maturing and liquidation of previously exempted trades over the transitional period;
2371
2372\[\frac{1-\omega_t}{1-\omega}\] =
2373
2374the transitional weighting, where ωt is calculated in accordance with the table in 7.2, and
2375
2376ω =
2377
23780.5.
2379
238001/01/2027
2381
23827.3
2383
2384For the purposes of 7.1(2), a firm must calculate:
2385
2386(a) the final discount scalar (\[\hat{\omega}_T\]) at the same frequency as it calculates its own funds requirement for CVA risk;
2387
2388(b) the transitional weighting cap (\[\omega_t\]) and the intermediate discount scalar (\[\bar{\omega}_t\]) as set out in 7.1(2) annually; and
2389
2390(c) the legacy exempt ratio on 1 January 2027, and recalculate the legacy exempt ratio at any point there is a material change in quantum or risk of the firm’s transactions with counterparties referred to in 7.1(1).
2391
239201/01/2027
2393
23947.4
2395
2396If, as of 1 January 2027, a firm has not chosen to exclude a transaction in accordance with 7.1(1), the firm must include the transaction in its calculation of its own funds requirements for CVA risk until the maturity date of the transaction.
2397
239801/01/2027
2399
24007.5